What We Do
SUPPORT IN EFFICIENT TRANSLATION
The translational roadmap for pluripotent stem cell (PSC/iPSC) therapeutic development is often obscure, yet efficient translation requires uncommon expertise. Beginning with the final medical product in mind, we will assist you develop your manufacturing process, enabling you develop a holistic vision for translation and a clear road map for efficient translation.
Expertise
Lindville Bio is an ATMP consultancy service specializing in the scalable manufacture of Pluripotent Stem Cells (PSC/iPSC) and therapeutic development therefrom.
Lindville Bio enables its clients clarify the translational roadmap for, and to accelerate the development of, PSC/iPSC-derived medicinal products and related technologies for a global market.
Specialist consulting service enabling efficient translation
About Lindville Bio
Our Approach
Efficient pluripotent stem cell (PSC/iPSC) translation requires expertise that spans multiple professional silos: researchers, registries and biobanks, GMP manufacturers, regulators, quality assessors, directed differentiation specialists, therapeutic developers, clinical trial managers, ATMP usability experts, logistics experts and ATMP market analysts. Our approach is to develop a holistic vision for translation, identifying all major hurdles from the beginning, and thereafter plotting the most efficient route to translation.
Why Us?
We are focused, knowledgable, lean and globally well networked - if we don't know, we will know who will.
Subscribe
Sign up to be updated on our pluripotent stem cell (PSC/iPSC) consultancy service.
Copyright © 2022 Lindville Bio - All Rights Reserved.
Powered by GoDaddy